Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

S2 Genomics Launches the Singulatortm 100 to Automate Tissue Preparation for Single-Cell and Single-Nucleus Analyses


S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT)?2020 meeting the launch of the Singulatortm 100 System. The Singulator 100 System automates the processing of solid tissue samples into suspensions of single cells or nuclei with high yields and from small samples for a wide range of single-cell biology and genomic analyses.

Automated tissue preparation workflows can help ensure high-quality single-cell data and accelerate single-cell research for genomics, cell biology, and other ?omic applications. The Singulator 100 automates and standardizes the dissociation process of solid tissues, making it easy for researchers to reproducibly prepare suspensions of high-quality, highly viable cells or nuclei with minimal variability.

"Current methods of cell isolation are often manual or require a series of manual interventions, creating a significant workflow bottleneck and experimental inconsistencies for single cell researchers. The Singulator 100 overcomes these challenges by rapidly producing consistent, reproducible cell or nuclei suspensions from solid tissue samples without user interventions, reducing hours of hands-on processing to minutes," said Dr. Stevan Jovanovich, President and CEO of S2 Genomics.

The Singulator 100 will begin shipping in spring 2020 with kits available for single-cell and nuclei isolation.

About S2 Genomics, Inc.

S2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissues for life science applications. S2 Genomics' technology platforms integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for the next generation sequencing (NGS) and cell biology markets, enabling discovery and innovation in life science research, healthcare, and agriculture. For more information, visit https://S2Genomics.com.

For Research Use Only. Not for use in diagnostic procedures.

S2 Genomics, the S2 Genomics logo, and Singulator are trademarks of S2 Genomics, Inc.


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: